Fri, May 17, 2024
Revenue increased to Rs 862 crore in the fourth quarter as against Rs 762 crore in the year-ago period, JB Chemicals & Pharmaceuticals said in a statement. For the year ended March 31, 2024, the company said its PAT increased 35 per cent to Rs 553 crore as compared with Rs 410 crore in FY23.
More >
Wed, Feb 07, 2024
Varinder Results Which companies including Birla Corp, JB Chemicals & Pharmaceuticals And Timken India had good and bad results? Know the result in X-RAY with Varinder Bansal..
Stock of the Day: Today Anil Singhvi gave buying advice in JB Chemicals and Radico Khaitan? What is stoploss and targets? See in this video...
Tue, Feb 06, 2024
The company reported a net profit of Rs 106 crore in the October-December period of the last fiscal.
Mon, Jun 12, 2023
JB Chemicals & Pharmaceuticals shares will trade ex-dividend on Rs 9.25 per share on August 17. The JB Chemicals stock, traded on the bourses with the symbol JBCHEPHARM, has risen 8.6 per cent so far in 2023.
Mon, Apr 25, 2022
The overall pharma sector to report flattish March quarter earnings, however, a few companies to benefit from the US market, Nirmal Bang said in its preview report.
Thu, Sep 30, 2021
Cardiovascular disease (CVD) is the leading cause of mortality and accounts for one-third of global deaths. Cardiac has displaced anti-infectives as the leading therapy in the India Pharma Market (IPM).
Wed, Sep 29, 2021
The company with a market capitalization of about Rs 15,000 cr hit a fresh 52-week high of Rs 1,984 on the BSE on 28 September. A potential move towards Rs 2,400 level translates into an upside of over 20 percent from Rs 1,955 hit on 28 September
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
